Association of hyperbilirubinemia in pazopanib- or sunitinib-treated patients in COMPARZ with UGT1A1 polymorphisms.
Toby Johnson
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Chun-fang Xu
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Toni K. Choueiri
Consultant or Advisory Role - AVEO; Bayer/Onyx; Genentech; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Pfizer
Keith C. Deen
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Zhengyu Xue
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Arundathy N. Bartlett-Pandite
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Christopher Carpenter
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Robert John Motzer
Consultant or Advisory Role - Genentech; Pfizer
Research Funding - Astellas Pharma; AVEO; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer